⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

AXGN

Axogen, Inc.

Healthcare · Medical Devices

43.44USD

-3.8300 (-8.11%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY138.6M159.0M187.3M225.2M279.6M331.1M
Q131.0M36.7M41.4M48.6M61.5M—
Q234.5M38.2M47.9M56.7M69.7M—
Q337.0M41.3M48.6M60.1M73.2M—
Q436.2M*42.9M*49.4M*59.9M*75.2M—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY-.690-.510-.230-.340.464.694
Q1-.270-.170-.150-.080-.380—
Q2-.180-.160-.040.010-.030—
Q3-.100-.100-.040.010.134—
Q4-.129*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

-.091*
.010*
-.286*
.136
—